Sen. Chuck Grassley (R-Iowa) wants to see his party’s leadership turn up the pressure on pharmacy benefit managers.
“They talk in such generalities on this subject that it’s difficult for me to tell where they’re coming from,” he said in a recent interview, speaking about top GOP senators’ approach to reforming the drug pricing middlemen who negotiate between pharmaceutical companies and insurers. “We’re hearing… ‘We don’t want to do something splitting the caucus.’ But we’ve got a major problem here with PBMs deciding rebates, deciding the price of drugs, probably being an instrument to drive up the price of drugs, and nobody knows what they’re doing.”
